

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 6.14771930 |
| 2 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.56582142 |
| 3 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.51844650 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 5.48476194 |
| 5 | DNA strand elongation (GO:0022616) | 5.28834013 |
| 6 | DNA deamination (GO:0045006) | 4.94390770 |
| 7 | DNA replication initiation (GO:0006270) | 4.91786325 |
| 8 | telomere maintenance via recombination (GO:0000722) | 4.88490105 |
| 9 | DNA unwinding involved in DNA replication (GO:0006268) | 4.70259956 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.58866922 |
| 11 | mitotic recombination (GO:0006312) | 4.51318998 |
| 12 | nucleobase biosynthetic process (GO:0046112) | 4.49029852 |
| 13 | cullin deneddylation (GO:0010388) | 4.36142810 |
| 14 | telomere maintenance via telomere lengthening (GO:0010833) | 4.28728514 |
| 15 | protein deneddylation (GO:0000338) | 4.28545835 |
| 16 | DNA replication checkpoint (GO:0000076) | 4.28164922 |
| 17 | maturation of SSU-rRNA (GO:0030490) | 4.27498270 |
| 18 | purine nucleobase biosynthetic process (GO:0009113) | 4.26364537 |
| 19 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 4.22818125 |
| 20 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 4.16060342 |
| 21 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.11084872 |
| 22 | nuclear envelope reassembly (GO:0031468) | 4.07537576 |
| 23 | mitotic nuclear envelope reassembly (GO:0007084) | 4.07537576 |
| 24 | viral transcription (GO:0019083) | 4.07319223 |
| 25 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.02977049 |
| 26 | proteasome assembly (GO:0043248) | 4.02430036 |
| 27 | protein retention in ER lumen (GO:0006621) | 4.01611201 |
| 28 | translational termination (GO:0006415) | 3.99617193 |
| 29 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.93917048 |
| 30 | cotranslational protein targeting to membrane (GO:0006613) | 3.92608899 |
| 31 | IMP biosynthetic process (GO:0006188) | 3.92068611 |
| 32 | protein targeting to ER (GO:0045047) | 3.89528975 |
| 33 | pentose-phosphate shunt (GO:0006098) | 3.89060424 |
| 34 | formation of translation preinitiation complex (GO:0001731) | 3.84198720 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.83911230 |
| 36 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.79171797 |
| 37 | CENP-A containing nucleosome assembly (GO:0034080) | 3.79132878 |
| 38 | translational elongation (GO:0006414) | 3.77467217 |
| 39 | establishment of integrated proviral latency (GO:0075713) | 3.75582424 |
| 40 | ribosomal small subunit biogenesis (GO:0042274) | 3.75305089 |
| 41 | chromatin remodeling at centromere (GO:0031055) | 3.73268909 |
| 42 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.70286075 |
| 43 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.70286075 |
| 44 | protein localization to endoplasmic reticulum (GO:0070972) | 3.68250984 |
| 45 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.66378078 |
| 46 | proline biosynthetic process (GO:0006561) | 3.61431118 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.59955754 |
| 48 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.59509221 |
| 49 | spliceosomal snRNP assembly (GO:0000387) | 3.56681647 |
| 50 | pseudouridine synthesis (GO:0001522) | 3.52756926 |
| 51 | pinocytosis (GO:0006907) | 3.48012940 |
| 52 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.45467491 |
| 53 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.45435750 |
| 54 | IMP metabolic process (GO:0046040) | 3.44808888 |
| 55 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.44272367 |
| 56 | DNA replication-independent nucleosome organization (GO:0034724) | 3.44272367 |
| 57 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.42758918 |
| 58 | translational initiation (GO:0006413) | 3.42711568 |
| 59 | ribosome biogenesis (GO:0042254) | 3.42219530 |
| 60 | histone arginine methylation (GO:0034969) | 3.41402833 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.40118542 |
| 62 | ribosomal large subunit biogenesis (GO:0042273) | 3.39859295 |
| 63 | protein localization to kinetochore (GO:0034501) | 3.38150357 |
| 64 | NADPH regeneration (GO:0006740) | 3.36797413 |
| 65 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.35098646 |
| 66 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.34500115 |
| 67 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.33744939 |
| 68 | glucose catabolic process (GO:0006007) | 3.32573278 |
| 69 | UV protection (GO:0009650) | 3.31564315 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.27861826 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.27861826 |
| 72 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.27545086 |
| 73 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.26762058 |
| 74 | cell cycle G1/S phase transition (GO:0044843) | 3.26051147 |
| 75 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.26051147 |
| 76 | viral life cycle (GO:0019058) | 3.25279661 |
| 77 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.24621453 |
| 78 | rRNA processing (GO:0006364) | 3.23302563 |
| 79 | rRNA modification (GO:0000154) | 3.23025212 |
| 80 | histone H2A acetylation (GO:0043968) | 3.22760807 |
| 81 | cellular protein complex disassembly (GO:0043624) | 3.22540944 |
| 82 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.22072798 |
| 83 | translation (GO:0006412) | 3.21017808 |
| 84 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.20604566 |
| 85 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.20604566 |
| 86 | viral mRNA export from host cell nucleus (GO:0046784) | 3.18421042 |
| 87 | peptidyl-arginine methylation (GO:0018216) | 3.16691939 |
| 88 | peptidyl-arginine N-methylation (GO:0035246) | 3.16691939 |
| 89 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.16229101 |
| 90 | telomere organization (GO:0032200) | 3.15086834 |
| 91 | mitochondrial calcium ion transport (GO:0006851) | 3.13937129 |
| 92 | spliceosomal complex assembly (GO:0000245) | 3.13418224 |
| 93 | telomere maintenance (GO:0000723) | 3.12575333 |
| 94 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.11882071 |
| 95 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.11230111 |
| 96 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.10748720 |
| 97 | Golgi transport vesicle coating (GO:0048200) | 3.08781647 |
| 98 | COPI coating of Golgi vesicle (GO:0048205) | 3.08781647 |
| 99 | rRNA metabolic process (GO:0016072) | 3.08425954 |
| 100 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.06856252 |
| 101 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.06734569 |
| 102 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.06734569 |
| 103 | oxidative phosphorylation (GO:0006119) | 3.06189125 |
| 104 | deoxyribonucleotide catabolic process (GO:0009264) | 3.04717877 |
| 105 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.03986644 |
| 106 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.03655793 |
| 107 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.03655793 |
| 108 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.03655793 |
| 109 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02867325 |
| 110 | maturation of 5.8S rRNA (GO:0000460) | 3.02702454 |
| 111 | postreplication repair (GO:0006301) | 3.02307249 |
| 112 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.00785764 |
| 113 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.00723891 |
| 114 | termination of RNA polymerase III transcription (GO:0006386) | 3.00723891 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.00068795 |
| 116 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.98185132 |
| 117 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.97113921 |
| 118 | deoxyribose phosphate catabolic process (GO:0046386) | 2.97104634 |
| 119 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.97041168 |
| 120 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.95950922 |
| 121 | protein complex disassembly (GO:0043241) | 2.95637157 |
| 122 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.95202215 |
| 123 | cellular component biogenesis (GO:0044085) | 2.95174314 |
| 124 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.95130027 |
| 125 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.95130027 |
| 126 | negative regulation of RNA splicing (GO:0033119) | 2.95058733 |
| 127 | establishment of viral latency (GO:0019043) | 2.94631119 |
| 128 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.94396964 |
| 129 | pentose metabolic process (GO:0019321) | 2.91675023 |
| 130 | purine nucleotide salvage (GO:0032261) | 2.90623186 |
| 131 | mitotic chromosome condensation (GO:0007076) | 2.89952543 |
| 132 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.88841488 |
| 133 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.87744662 |
| 134 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.86967707 |
| 135 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.86967707 |
| 136 | protein-DNA complex disassembly (GO:0032986) | 2.84849493 |
| 137 | nucleosome disassembly (GO:0006337) | 2.84849493 |
| 138 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.84503238 |
| 139 | autophagic vacuole fusion (GO:0000046) | 2.83418280 |
| 140 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.82101336 |
| 141 | de novo protein folding (GO:0006458) | 2.80934093 |
| 142 | deoxyribose phosphate metabolic process (GO:0019692) | 2.80697268 |
| 143 | de novo posttranslational protein folding (GO:0051084) | 2.80593356 |
| 144 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.80388007 |
| 145 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.79607606 |
| 146 | nucleotide salvage (GO:0043173) | 2.79514712 |
| 147 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.78935029 |
| 148 | barbed-end actin filament capping (GO:0051016) | 2.75548843 |
| 149 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.74288337 |
| 150 | iron-sulfur cluster assembly (GO:0016226) | 2.73465040 |
| 151 | metallo-sulfur cluster assembly (GO:0031163) | 2.73465040 |
| 152 | protein localization to endosome (GO:0036010) | 2.72998302 |
| 153 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.71795087 |
| 154 | NADH metabolic process (GO:0006734) | 2.71538203 |
| 155 | adenine nucleotide transport (GO:0051503) | 2.70685187 |
| 156 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67199575 |
| 157 | deoxyribonucleotide metabolic process (GO:0009262) | 2.64340208 |
| 158 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.63691360 |
| 159 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.62013122 |
| 160 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61371283 |
| 161 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.58909325 |
| 162 | negative regulation of cell size (GO:0045792) | 2.58438508 |
| 163 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.57811383 |
| 164 | prostaglandin biosynthetic process (GO:0001516) | 2.57224666 |
| 165 | prostanoid biosynthetic process (GO:0046457) | 2.57224666 |
| 166 | virion assembly (GO:0019068) | 2.56299164 |
| 167 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.54632532 |
| 168 | heme biosynthetic process (GO:0006783) | 2.46867282 |
| 169 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.44586353 |
| 170 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.42968443 |
| 171 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.41936889 |
| 172 | extracellular fibril organization (GO:0043206) | 2.41480210 |
| 173 | mitochondrial fusion (GO:0008053) | 2.40772551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.52771007 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.48614465 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.21395661 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.84126074 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.41238952 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.40078992 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.33529290 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.32472751 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.26925981 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.19908417 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.08640651 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.02558418 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.94813537 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.93287505 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.78643479 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.75869142 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.52784871 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49972804 |
| 19 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.46921787 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.36844337 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.33175700 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32563053 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31506784 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.31311204 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.25414093 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20058159 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.18916459 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.16268613 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.14634440 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11176495 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07729610 |
| 32 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.05959090 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96494562 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96412529 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94246256 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.89382078 |
| 37 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.88404950 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.87941972 |
| 39 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87247901 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86141278 |
| 41 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.85508588 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84624410 |
| 43 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.84130920 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83263346 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82055633 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81426200 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.80875132 |
| 48 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79665600 |
| 49 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77484388 |
| 50 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.77273647 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77080597 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70925661 |
| 53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69859855 |
| 54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68881106 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.68821150 |
| 56 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.67797885 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.67263601 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.64305577 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62463543 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.61741659 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60048871 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.58447121 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.57018166 |
| 64 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.56763503 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.49104306 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47953040 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43101917 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42313541 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37223827 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.33890468 |
| 71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32277859 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31269505 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29871550 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27152885 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26770878 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25286449 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25235880 |
| 78 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.22171073 |
| 79 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21574659 |
| 80 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21490703 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.19784167 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17594095 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 1.15839742 |
| 84 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.15782658 |
| 85 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15547965 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15176649 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14549538 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13527647 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12146545 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10516472 |
| 91 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09970192 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08713536 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.08140821 |
| 94 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07575448 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05543183 |
| 96 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05398747 |
| 97 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04879545 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04717262 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04510768 |
| 100 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04021699 |
| 101 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03672616 |
| 102 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03267018 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03264879 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02066938 |
| 105 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02048510 |
| 106 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01816077 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99712932 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99462224 |
| 109 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99368489 |
| 110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99253904 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98777292 |
| 112 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97081272 |
| 113 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95937410 |
| 114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94721522 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94092953 |
| 116 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92796002 |
| 117 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91649427 |
| 118 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.90187764 |
| 119 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89384336 |
| 120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87905093 |
| 121 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.86732076 |
| 122 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84636534 |
| 123 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82315498 |
| 124 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81817860 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81702448 |
| 126 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.79339677 |
| 127 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77280606 |
| 128 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.76661134 |
| 129 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.74976617 |
| 130 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71536261 |
| 131 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.71527244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.41971267 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.51253971 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.40408562 |
| 4 | MP0005058_abnormal_lysosome_morphology | 4.36345276 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.72843131 |
| 6 | MP0003123_paternal_imprinting | 3.72186740 |
| 7 | MP0003077_abnormal_cell_cycle | 3.69263017 |
| 8 | MP0008057_abnormal_DNA_replication | 3.35843823 |
| 9 | MP0008058_abnormal_DNA_repair | 3.33203559 |
| 10 | MP0005464_abnormal_platelet_physiology | 3.29551796 |
| 11 | MP0008007_abnormal_cellular_replicative | 3.22290148 |
| 12 | MP0009278_abnormal_bone_marrow | 3.20017259 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.79279817 |
| 14 | MP0008260_abnormal_autophagy | 2.73512832 |
| 15 | MP0005451_abnormal_body_composition | 2.69132511 |
| 16 | MP0006054_spinal_hemorrhage | 2.68650986 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.63965691 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.57192439 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.43243613 |
| 20 | MP0009379_abnormal_foot_pigmentation | 2.43010832 |
| 21 | MP0009840_abnormal_foam_cell | 2.42833644 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.24598894 |
| 23 | MP0003121_genomic_imprinting | 2.19949294 |
| 24 | MP0000490_abnormal_crypts_of | 2.06481949 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.99274443 |
| 26 | MP0003122_maternal_imprinting | 1.97119390 |
| 27 | MP0005501_abnormal_skin_physiology | 1.94488267 |
| 28 | MP0000350_abnormal_cell_proliferation | 1.90892806 |
| 29 | MP0003786_premature_aging | 1.80520139 |
| 30 | MP0000343_altered_response_to | 1.77349599 |
| 31 | MP0001730_embryonic_growth_arrest | 1.76157052 |
| 32 | MP0010030_abnormal_orbit_morphology | 1.75768598 |
| 33 | MP0004233_abnormal_muscle_weight | 1.73510323 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.71953181 |
| 35 | MP0002938_white_spotting | 1.59843442 |
| 36 | MP0000681_abnormal_thyroid_gland | 1.57965045 |
| 37 | MP0005165_increased_susceptibility_to | 1.56274427 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.55500394 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.51745086 |
| 40 | MP0003075_altered_response_to | 1.50792511 |
| 41 | MP0003315_abnormal_perineum_morphology | 1.48505196 |
| 42 | MP0002796_impaired_skin_barrier | 1.45845731 |
| 43 | MP0005083_abnormal_biliary_tract | 1.45750432 |
| 44 | MP0001727_abnormal_embryo_implantation | 1.45637140 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.42050420 |
| 46 | MP0000313_abnormal_cell_death | 1.39899687 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.39878457 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.37551644 |
| 49 | MP0002080_prenatal_lethality | 1.37539635 |
| 50 | MP0001697_abnormal_embryo_size | 1.35789697 |
| 51 | MP0002160_abnormal_reproductive_system | 1.35535098 |
| 52 | MP0003329_amyloid_beta_deposits | 1.34892146 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.34846984 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.33950942 |
| 55 | MP0003186_abnormal_redox_activity | 1.32620255 |
| 56 | MP0001849_ear_inflammation | 1.31162579 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.26961993 |
| 58 | MP0001188_hyperpigmentation | 1.26276609 |
| 59 | MP0001881_abnormal_mammary_gland | 1.26223333 |
| 60 | MP0000358_abnormal_cell_content/ | 1.24643479 |
| 61 | MP0008789_abnormal_olfactory_epithelium | 1.21324300 |
| 62 | MP0000750_abnormal_muscle_regeneration | 1.20744947 |
| 63 | MP0001529_abnormal_vocalization | 1.19647369 |
| 64 | MP0001853_heart_inflammation | 1.19010628 |
| 65 | MP0001542_abnormal_bone_strength | 1.18021402 |
| 66 | MP0000751_myopathy | 1.15175554 |
| 67 | MP0005257_abnormal_intraocular_pressure | 1.14483539 |
| 68 | MP0002210_abnormal_sex_determination | 1.14238872 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 1.13118992 |
| 70 | MP0003718_maternal_effect | 1.12686718 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 1.12615289 |
| 72 | MP0001672_abnormal_embryogenesis/_devel | 1.11741649 |
| 73 | MP0005380_embryogenesis_phenotype | 1.11741649 |
| 74 | MP0002085_abnormal_embryonic_tissue | 1.09823839 |
| 75 | MP0004858_abnormal_nervous_system | 1.08962349 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.08757520 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.08757520 |
| 78 | MP0003119_abnormal_digestive_system | 1.06901701 |
| 79 | MP0000747_muscle_weakness | 1.06631214 |
| 80 | MP0009697_abnormal_copulation | 1.05398262 |
| 81 | MP0003890_abnormal_embryonic-extraembry | 1.04749395 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.04650038 |
| 83 | MP0002095_abnormal_skin_pigmentation | 1.02249944 |
| 84 | MP0003984_embryonic_growth_retardation | 1.01273998 |
| 85 | MP0000566_synostosis | 1.00392215 |
| 86 | MP0001145_abnormal_male_reproductive | 1.00083982 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.98872558 |
| 88 | MP0005499_abnormal_olfactory_system | 0.98872558 |
| 89 | MP0002132_abnormal_respiratory_system | 0.98606296 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.98605864 |
| 91 | MP0002088_abnormal_embryonic_growth/wei | 0.98085061 |
| 92 | MP0000858_altered_metastatic_potential | 0.96906644 |
| 93 | MP0001119_abnormal_female_reproductive | 0.96895359 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.96750567 |
| 95 | MP0005389_reproductive_system_phenotype | 0.96031522 |
| 96 | MP0005621_abnormal_cell_physiology | 0.94826684 |
| 97 | MP0001243_abnormal_dermal_layer | 0.94011481 |
| 98 | MP0002084_abnormal_developmental_patter | 0.93771900 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.93070872 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.93065418 |
| 101 | MP0002163_abnormal_gland_morphology | 0.93028829 |
| 102 | MP0002429_abnormal_blood_cell | 0.91015729 |
| 103 | MP0008874_decreased_physiological_sensi | 0.90600866 |
| 104 | MP0000653_abnormal_sex_gland | 0.90066009 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.89418936 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.88705395 |
| 107 | MP0005330_cardiomyopathy | 0.87470492 |
| 108 | MP0004147_increased_porphyrin_level | 0.86822842 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.86756532 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.86372503 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.86304024 |
| 112 | MP0003787_abnormal_imprinting | 0.86179537 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.83781743 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.83502083 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.83499572 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.83313508 |
| 117 | MP0000604_amyloidosis | 0.83277137 |
| 118 | MP0003436_decreased_susceptibility_to | 0.82671494 |
| 119 | MP0000537_abnormal_urethra_morphology | 0.82508808 |
| 120 | MP0004197_abnormal_fetal_growth/weight/ | 0.81402033 |
| 121 | MP0000049_abnormal_middle_ear | 0.80905353 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.80433694 |
| 123 | MP0001905_abnormal_dopamine_level | 0.80194302 |
| 124 | MP0010307_abnormal_tumor_latency | 0.79613358 |
| 125 | MP0009931_abnormal_skin_appearance | 0.79424638 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.78772472 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.78132981 |
| 128 | MP0002086_abnormal_extraembryonic_tissu | 0.77175454 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.76698131 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.76056720 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.75928776 |
| 132 | MP0004133_heterotaxia | 0.75767943 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.75632019 |
| 134 | MP0005646_abnormal_pituitary_gland | 0.75097076 |
| 135 | MP0001929_abnormal_gametogenesis | 0.74914585 |
| 136 | MP0001919_abnormal_reproductive_system | 0.74804913 |
| 137 | MP0003183_abnormal_peptide_metabolism | 0.74727269 |
| 138 | MP0002398_abnormal_bone_marrow | 0.74605565 |
| 139 | MP0002653_abnormal_ependyma_morphology | 0.73812941 |
| 140 | MP0003942_abnormal_urinary_system | 0.73254520 |
| 141 | MP0002722_abnormal_immune_system | 0.73042172 |
| 142 | MP0000689_abnormal_spleen_morphology | 0.72757575 |
| 143 | MP0005266_abnormal_metabolism | 0.72242925 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.71943648 |
| 145 | MP0005384_cellular_phenotype | 0.71864561 |
| 146 | MP0010352_gastrointestinal_tract_polyps | 0.71537110 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.68983005 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68963486 |
| 149 | MP0004510_myositis | 0.67946425 |
| 150 | MP0009672_abnormal_birth_weight | 0.67897209 |
| 151 | MP0003943_abnormal_hepatobiliary_system | 0.67887966 |
| 152 | MP0010771_integument_phenotype | 0.67433303 |
| 153 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64618460 |
| 154 | MP0002060_abnormal_skin_morphology | 0.64134070 |
| 155 | MP0000627_abnormal_mammary_gland | 0.62467747 |
| 156 | MP0005000_abnormal_immune_tolerance | 0.62107586 |
| 157 | MP0001216_abnormal_epidermal_layer | 0.61512545 |
| 158 | MP0009763_increased_sensitivity_to | 0.60081046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.73778166 |
| 2 | Reticulocytopenia (HP:0001896) | 4.50323430 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 4.14657869 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 4.12110871 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.09695946 |
| 6 | Oral leukoplakia (HP:0002745) | 3.99994669 |
| 7 | Type I transferrin isoform profile (HP:0003642) | 3.96370328 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.58421826 |
| 9 | Cholecystitis (HP:0001082) | 3.55676127 |
| 10 | Abnormal gallbladder physiology (HP:0012438) | 3.55676127 |
| 11 | Degeneration of anterior horn cells (HP:0002398) | 3.50994393 |
| 12 | Abnormality of the anterior horn cell (HP:0006802) | 3.50994393 |
| 13 | 11 pairs of ribs (HP:0000878) | 3.44354668 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.33804774 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.33804774 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.27709732 |
| 17 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.21281548 |
| 18 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.21281548 |
| 19 | Abnormal protein glycosylation (HP:0012346) | 3.21281548 |
| 20 | Abnormal glycosylation (HP:0012345) | 3.21281548 |
| 21 | Reduced antithrombin III activity (HP:0001976) | 3.17944953 |
| 22 | Hyperacusis (HP:0010780) | 3.10052388 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07175943 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07175943 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07175943 |
| 26 | Colon cancer (HP:0003003) | 3.05829080 |
| 27 | Hepatocellular necrosis (HP:0001404) | 3.05663526 |
| 28 | Achilles tendon contracture (HP:0001771) | 3.02691226 |
| 29 | Thrombocytosis (HP:0001894) | 3.02247985 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 3.01644839 |
| 31 | Petechiae (HP:0000967) | 3.00047934 |
| 32 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.97336227 |
| 33 | Rough bone trabeculation (HP:0100670) | 2.95898814 |
| 34 | Microretrognathia (HP:0000308) | 2.94436142 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.84787253 |
| 36 | Hepatic necrosis (HP:0002605) | 2.82678067 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.82432191 |
| 38 | Breast hypoplasia (HP:0003187) | 2.82338790 |
| 39 | Distal lower limb amyotrophy (HP:0008944) | 2.77453923 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.76783687 |
| 41 | Insomnia (HP:0100785) | 2.76253548 |
| 42 | Increased CSF lactate (HP:0002490) | 2.75506760 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.72175187 |
| 44 | Chromsome breakage (HP:0040012) | 2.71935936 |
| 45 | Pallor (HP:0000980) | 2.71125921 |
| 46 | Increased hepatocellular lipid droplets (HP:0006565) | 2.70983639 |
| 47 | Premature graying of hair (HP:0002216) | 2.70932979 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.70269356 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68944232 |
| 50 | Reticulocytosis (HP:0001923) | 2.66596900 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65108501 |
| 52 | Macrocytic anemia (HP:0001972) | 2.64934023 |
| 53 | Hypertensive crisis (HP:0100735) | 2.64915077 |
| 54 | Increased serum lactate (HP:0002151) | 2.64910911 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.63685726 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.62195022 |
| 57 | Purpura (HP:0000979) | 2.57096694 |
| 58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.52315934 |
| 59 | Selective tooth agenesis (HP:0001592) | 2.51410223 |
| 60 | Lipid accumulation in hepatocytes (HP:0006561) | 2.48580589 |
| 61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48401593 |
| 62 | Pancytopenia (HP:0001876) | 2.44663495 |
| 63 | Patellar aplasia (HP:0006443) | 2.44350864 |
| 64 | Growth hormone excess (HP:0000845) | 2.42669599 |
| 65 | Abnormality of the preputium (HP:0100587) | 2.41762388 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.41161302 |
| 67 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.41092163 |
| 68 | Fasciculations (HP:0002380) | 2.39648441 |
| 69 | Slender long bone (HP:0003100) | 2.38873880 |
| 70 | Abnormality of reticulocytes (HP:0004312) | 2.34114308 |
| 71 | Upper limb muscle weakness (HP:0003484) | 2.33601304 |
| 72 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.33513905 |
| 73 | Abnormality of the ileum (HP:0001549) | 2.32441991 |
| 74 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.32343861 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32007450 |
| 76 | Neoplasm of the pancreas (HP:0002894) | 2.30788478 |
| 77 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.30171596 |
| 78 | Meckel diverticulum (HP:0002245) | 2.29606087 |
| 79 | Myelodysplasia (HP:0002863) | 2.28151290 |
| 80 | Agnosia (HP:0010524) | 2.27512489 |
| 81 | Bone marrow hypocellularity (HP:0005528) | 2.27204842 |
| 82 | Medulloblastoma (HP:0002885) | 2.22657665 |
| 83 | Hyperthyroidism (HP:0000836) | 2.22210159 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.21772646 |
| 85 | Missing ribs (HP:0000921) | 2.21733662 |
| 86 | Abnormality of the umbilical cord (HP:0010881) | 2.20419445 |
| 87 | Cholelithiasis (HP:0001081) | 2.20178973 |
| 88 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.19721935 |
| 89 | Abnormality of chromosome stability (HP:0003220) | 2.17872709 |
| 90 | Back pain (HP:0003418) | 2.17635966 |
| 91 | Exertional dyspnea (HP:0002875) | 2.16963153 |
| 92 | Ependymoma (HP:0002888) | 2.16138132 |
| 93 | Trismus (HP:0000211) | 2.15840177 |
| 94 | Cerebral palsy (HP:0100021) | 2.14536945 |
| 95 | Carpal bone hypoplasia (HP:0001498) | 2.14456593 |
| 96 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.13765555 |
| 97 | Acute encephalopathy (HP:0006846) | 2.12898560 |
| 98 | Respiratory difficulties (HP:0002880) | 2.12182732 |
| 99 | Abnormal lung lobation (HP:0002101) | 2.11577706 |
| 100 | Prolonged neonatal jaundice (HP:0006579) | 2.11536807 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.11403154 |
| 102 | Exercise intolerance (HP:0003546) | 2.11263471 |
| 103 | Increased muscle lipid content (HP:0009058) | 2.10715398 |
| 104 | Optic nerve coloboma (HP:0000588) | 2.08535821 |
| 105 | Hypoplasia of the pons (HP:0012110) | 2.07132950 |
| 106 | Absent thumb (HP:0009777) | 2.06006876 |
| 107 | Premature rupture of membranes (HP:0001788) | 2.05989436 |
| 108 | Increased serum ferritin (HP:0003281) | 2.05378365 |
| 109 | Myoglobinuria (HP:0002913) | 2.04493093 |
| 110 | Orthostatic hypotension (HP:0001278) | 2.03894997 |
| 111 | Microvesicular hepatic steatosis (HP:0001414) | 2.03462359 |
| 112 | Insidious onset (HP:0003587) | 2.03419070 |
| 113 | Termporal pattern (HP:0011008) | 2.03419070 |
| 114 | Abnormality of the tricuspid valve (HP:0001702) | 2.02392007 |
| 115 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.99784618 |
| 116 | Lactic acidosis (HP:0003128) | 1.99730065 |
| 117 | Broad distal phalanx of finger (HP:0009836) | 1.97643418 |
| 118 | Rhabdomyolysis (HP:0003201) | 1.97437718 |
| 119 | Microglossia (HP:0000171) | 1.97425152 |
| 120 | Abnormal trabecular bone morphology (HP:0100671) | 1.96849527 |
| 121 | Abnormality of glycolysis (HP:0004366) | 1.95353141 |
| 122 | Increased serum pyruvate (HP:0003542) | 1.95353141 |
| 123 | Testicular atrophy (HP:0000029) | 1.92844703 |
| 124 | Embryonal renal neoplasm (HP:0011794) | 1.92021099 |
| 125 | Multiple enchondromatosis (HP:0005701) | 1.91429201 |
| 126 | Duodenal stenosis (HP:0100867) | 1.91076464 |
| 127 | Small intestinal stenosis (HP:0012848) | 1.91076464 |
| 128 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91049255 |
| 129 | Unsteady gait (HP:0002317) | 1.90004299 |
| 130 | Cellular immunodeficiency (HP:0005374) | 1.88833649 |
| 131 | Secondary amenorrhea (HP:0000869) | 1.88146102 |
| 132 | IgM deficiency (HP:0002850) | 1.87914828 |
| 133 | Loss of speech (HP:0002371) | 1.87132712 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.86840025 |
| 135 | Diminished motivation (HP:0000745) | 1.86166593 |
| 136 | Tracheoesophageal fistula (HP:0002575) | 1.85476143 |
| 137 | Abnormal platelet function (HP:0011869) | 1.85210391 |
| 138 | Impaired platelet aggregation (HP:0003540) | 1.85210391 |
| 139 | Entropion (HP:0000621) | 1.83937280 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.83329196 |
| 141 | Horseshoe kidney (HP:0000085) | 1.83321396 |
| 142 | Lower limb amyotrophy (HP:0007210) | 1.83147438 |
| 143 | Emotional lability (HP:0000712) | 1.82413046 |
| 144 | Patellar dislocation (HP:0002999) | 1.81166166 |
| 145 | Hyperparathyroidism (HP:0000843) | 1.80785092 |
| 146 | Increased mean platelet volume (HP:0011877) | 1.80295847 |
| 147 | Neuroblastic tumors (HP:0004376) | 1.79857776 |
| 148 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.79857776 |
| 149 | Neuroblastoma (HP:0003006) | 1.79857776 |
| 150 | Primitive neuroectodermal tumor (HP:0030065) | 1.79857776 |
| 151 | Abnormality of lateral ventricle (HP:0030047) | 1.79764471 |
| 152 | Sloping forehead (HP:0000340) | 1.78975055 |
| 153 | Seborrheic dermatitis (HP:0001051) | 1.78559609 |
| 154 | Renal Fanconi syndrome (HP:0001994) | 1.78169196 |
| 155 | Myopathic facies (HP:0002058) | 1.78159347 |
| 156 | Prolonged bleeding time (HP:0003010) | 1.78056791 |
| 157 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78044978 |
| 158 | Abnormality of the pons (HP:0007361) | 1.76897145 |
| 159 | Menorrhagia (HP:0000132) | 1.76230825 |
| 160 | Facial cleft (HP:0002006) | 1.75644715 |
| 161 | Muscle stiffness (HP:0003552) | 1.75099281 |
| 162 | Pendular nystagmus (HP:0012043) | 1.74873876 |
| 163 | Distal upper limb amyotrophy (HP:0007149) | 1.74684305 |
| 164 | Upper limb amyotrophy (HP:0009129) | 1.74684305 |
| 165 | Hypokinesia (HP:0002375) | 1.74307344 |
| 166 | Acute lymphatic leukemia (HP:0006721) | 1.74260553 |
| 167 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.74206137 |
| 168 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.74206137 |
| 169 | Single umbilical artery (HP:0001195) | 1.74206137 |
| 170 | Muscle fiber atrophy (HP:0100295) | 1.74161886 |
| 171 | Abnormal gallbladder morphology (HP:0012437) | 1.74013652 |
| 172 | Generalized amyotrophy (HP:0003700) | 1.72982880 |
| 173 | Overriding aorta (HP:0002623) | 1.72049422 |
| 174 | Spinal rigidity (HP:0003306) | 1.71951697 |
| 175 | Shoulder girdle muscle weakness (HP:0003547) | 1.70830416 |
| 176 | Progressive neurologic deterioration (HP:0002344) | 1.68658963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.07254314 |
| 2 | CDC7 | 3.76613951 |
| 3 | WEE1 | 3.64941688 |
| 4 | PASK | 3.52591804 |
| 5 | STK16 | 3.48926801 |
| 6 | VRK2 | 3.37722825 |
| 7 | EIF2AK1 | 3.02448594 |
| 8 | ACVR1B | 2.87544198 |
| 9 | IRAK3 | 2.84092515 |
| 10 | VRK1 | 2.53027412 |
| 11 | TSSK6 | 2.40594827 |
| 12 | TRIB3 | 2.37627553 |
| 13 | EIF2AK3 | 2.32473926 |
| 14 | BRSK2 | 2.26995932 |
| 15 | NEK1 | 2.23387626 |
| 16 | ERN1 | 2.16743663 |
| 17 | CDK8 | 2.12467939 |
| 18 | SCYL2 | 2.11357622 |
| 19 | CCNB1 | 2.02741110 |
| 20 | SMG1 | 2.01343600 |
| 21 | FLT3 | 1.93562093 |
| 22 | TGFBR1 | 1.80838607 |
| 23 | BRSK1 | 1.80585975 |
| 24 | SRPK1 | 1.76074032 |
| 25 | TESK2 | 1.69212013 |
| 26 | DYRK3 | 1.68559222 |
| 27 | NME2 | 1.66812583 |
| 28 | MKNK1 | 1.65596349 |
| 29 | CDK7 | 1.50634726 |
| 30 | NEK2 | 1.50446587 |
| 31 | PLK1 | 1.48685088 |
| 32 | PRPF4B | 1.46339621 |
| 33 | BCKDK | 1.38457582 |
| 34 | ATR | 1.37680161 |
| 35 | MAP3K12 | 1.36949962 |
| 36 | PLK4 | 1.35818386 |
| 37 | TTK | 1.34262661 |
| 38 | BRAF | 1.32633084 |
| 39 | PIM2 | 1.31952055 |
| 40 | TLK1 | 1.27562204 |
| 41 | KDR | 1.24375423 |
| 42 | RPS6KB2 | 1.22087075 |
| 43 | RPS6KA4 | 1.21374507 |
| 44 | AURKB | 1.21327512 |
| 45 | PLK3 | 1.20646698 |
| 46 | CDK19 | 1.11542441 |
| 47 | DAPK1 | 1.10349357 |
| 48 | PAK4 | 1.09009180 |
| 49 | TESK1 | 1.05745843 |
| 50 | EPHA2 | 1.01893742 |
| 51 | CSNK1G3 | 1.00318775 |
| 52 | CDK14 | 0.99777998 |
| 53 | MKNK2 | 0.97314337 |
| 54 | AURKA | 0.97313799 |
| 55 | ABL2 | 0.96151690 |
| 56 | CHEK2 | 0.88623702 |
| 57 | CDK15 | 0.87029206 |
| 58 | YES1 | 0.86499142 |
| 59 | ICK | 0.86086086 |
| 60 | SIK1 | 0.84510581 |
| 61 | SIK3 | 0.81945539 |
| 62 | TBK1 | 0.81645043 |
| 63 | LIMK1 | 0.79390254 |
| 64 | KIT | 0.78837296 |
| 65 | BMX | 0.77267450 |
| 66 | TTN | 0.76857563 |
| 67 | TEC | 0.75771105 |
| 68 | CAMKK2 | 0.73950127 |
| 69 | DAPK3 | 0.71552535 |
| 70 | CDK4 | 0.70717956 |
| 71 | MAP3K11 | 0.70204102 |
| 72 | ERBB3 | 0.69483660 |
| 73 | MAP2K3 | 0.68587403 |
| 74 | CHEK1 | 0.68282722 |
| 75 | CSNK2A1 | 0.68260220 |
| 76 | LMTK2 | 0.67054722 |
| 77 | DYRK2 | 0.66062046 |
| 78 | MAPKAPK3 | 0.64268123 |
| 79 | BTK | 0.63638672 |
| 80 | CSNK2A2 | 0.61684079 |
| 81 | CAMK2G | 0.61180223 |
| 82 | CSNK1A1L | 0.59173005 |
| 83 | NME1 | 0.57694079 |
| 84 | PBK | 0.57339668 |
| 85 | TAOK1 | 0.57148354 |
| 86 | MYLK | 0.56178094 |
| 87 | MAP3K8 | 0.56005455 |
| 88 | EEF2K | 0.52717279 |
| 89 | CDK2 | 0.51699133 |
| 90 | CSF1R | 0.51502727 |
| 91 | UHMK1 | 0.50709776 |
| 92 | CSNK1G2 | 0.50379208 |
| 93 | PAK1 | 0.49926394 |
| 94 | NTRK1 | 0.49210652 |
| 95 | MAP2K2 | 0.49164233 |
| 96 | MOS | 0.48084359 |
| 97 | ILK | 0.46834561 |
| 98 | PAK2 | 0.45960204 |
| 99 | ATM | 0.45844214 |
| 100 | PTK2 | 0.45670544 |
| 101 | EIF2AK2 | 0.45509295 |
| 102 | BMPR1B | 0.44854924 |
| 103 | AKT2 | 0.44186254 |
| 104 | PRKCI | 0.43406905 |
| 105 | PIK3CG | 0.43401292 |
| 106 | WNK3 | 0.41371787 |
| 107 | PKN2 | 0.40978262 |
| 108 | CAMK2B | 0.39020095 |
| 109 | LRRK2 | 0.38954247 |
| 110 | NEK9 | 0.38127748 |
| 111 | ARAF | 0.37160879 |
| 112 | ADRBK2 | 0.36288106 |
| 113 | PIM1 | 0.35609657 |
| 114 | MAPK13 | 0.34570758 |
| 115 | MAP3K1 | 0.34512128 |
| 116 | PTK6 | 0.34352149 |
| 117 | TAOK2 | 0.34191766 |
| 118 | CDK1 | 0.34162729 |
| 119 | MAPKAPK2 | 0.32112230 |
| 120 | ZAP70 | 0.31500724 |
| 121 | RAF1 | 0.31098961 |
| 122 | CLK1 | 0.30873783 |
| 123 | MINK1 | 0.30779466 |
| 124 | CAMK2D | 0.30752541 |
| 125 | CDK18 | 0.30671622 |
| 126 | RPS6KA5 | 0.30275273 |
| 127 | MAP2K6 | 0.29139983 |
| 128 | IRAK4 | 0.28861660 |
| 129 | CDK11A | 0.28853911 |
| 130 | LATS2 | 0.28586647 |
| 131 | ZAK | 0.28466150 |
| 132 | IRAK2 | 0.28002115 |
| 133 | CSNK1G1 | 0.27721563 |
| 134 | HIPK2 | 0.27508955 |
| 135 | MAPK11 | 0.27046445 |
| 136 | CAMKK1 | 0.26927605 |
| 137 | MATK | 0.26758636 |
| 138 | RPS6KL1 | 0.26472940 |
| 139 | RPS6KC1 | 0.26472940 |
| 140 | MAP2K7 | 0.26407813 |
| 141 | MAPKAPK5 | 0.26323881 |
| 142 | TRIM28 | 0.25756393 |
| 143 | RIPK4 | 0.25587399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.71859461 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.66734425 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.82176891 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.68094640 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 3.39457857 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 3.21696065 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 3.12371640 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 3.03269504 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.98426125 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.93139904 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.75547849 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.59322142 |
| 13 | * RNA transport_Homo sapiens_hsa03013 | 2.48475251 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 2.46269347 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.44847011 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.36771390 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.27487128 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.93496921 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.83992693 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80366479 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.74945693 |
| 22 | Purine metabolism_Homo sapiens_hsa00230 | 1.56808336 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.55022566 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.47817357 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.37551142 |
| 26 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.30992674 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29452542 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25577077 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21225670 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.16847511 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16808862 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15429576 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.14729944 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.11460461 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.08669581 |
| 36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06158878 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98840626 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96325013 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92317475 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.90687044 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89386206 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88712949 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86884976 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85883209 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84792905 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83405746 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83126795 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82436811 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81453618 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79970138 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75931448 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75522500 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75232154 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.74400291 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73493272 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71725045 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70164911 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68081096 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66913140 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66794352 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.64165830 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.62774874 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62334385 |
| 64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.62157187 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61074381 |
| 66 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60832585 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59275543 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.58142817 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56738385 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55826749 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55307023 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54227739 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48446427 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47694925 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47535317 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47370234 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44250565 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42604766 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42264504 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41639281 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40979944 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39792695 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38356975 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35843672 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34707777 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34499208 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.33639800 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32820028 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.32267396 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31650910 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30994476 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27103351 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26304010 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25630753 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.24653698 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24478142 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24124612 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24050203 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.20852617 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20215341 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19639509 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19552585 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18994175 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16628988 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15388532 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14909859 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.13874869 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.13533316 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.13323416 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12140167 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10833048 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.08377867 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08293375 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06086040 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.03223881 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.02166478 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.01603619 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.00821497 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.00260803 |
| 120 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.00107525 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | -0.0621733 |
| 122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | -0.0601333 |
| 123 | Influenza A_Homo sapiens_hsa05164 | -0.0581464 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0480001 |
| 125 | Measles_Homo sapiens_hsa05162 | -0.0421233 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0267564 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0146760 |

